Drug Shortage Report for AURO-REPAGLINIDE

Last updated on 2019-05-17 History
Report ID 72027
Drug Identification Number 02424266
Brand name AURO-REPAGLINIDE
Common or Proper name Repaglinide
Company Name AURO PHARMA INC
Active Ingredient(s) REPAGLINIDE
Strength(s) 1MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code A10BX
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-01-11
Estimated end date 2019-06-14
Actual end date
Shortage status Actual shortage
Updated date 2019-05-17
Company comments Available - Limited stock
Health Canada comments
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Balaji Srinivasan

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2019-05-17 French Compare
v18 2019-05-17 English Compare
v17 2019-05-14 French Compare
v16 2019-05-14 English Compare
v15 2019-04-11 French Compare
v14 2019-04-11 English Compare
v13 2019-03-06 French Compare
v12 2019-03-06 English Compare
v11 2019-02-28 French Compare
v10 2019-02-28 English Compare
v9 2019-02-20 French Compare
v8 2019-02-20 English Compare
v7 2019-02-13 French Compare
v6 2019-02-13 English Compare
v5 2019-01-22 French Compare
v4 2019-01-22 English Compare
v3 2019-01-12 English Compare
v2 2019-01-11 French Compare
v1 2019-01-11 English Compare